The addition of albumin-bound paclitaxel (nab-paclitaxel) to the treatment standard gemcitabine significantly lengthened survival in patients with metastatic pancreatic cancer
Jill Stein
Advertisement
Articles by Jill Stein
Older patients with advanced hematologic malignancies who receive a minimally toxic nonmyeloablative regimen before allogeneic HCT have favorable OS and PFS rates.
New findings demonstrate a recent increase in the annual completion rates of vaccination against human papillomavirus (HPV) infection.
Advertisement
Latest Updated Articles
- Nab-Paclitaxel Boosts Survival in Pancreatic Cancer
January 10th 2014
- HPV Vaccination Completion Rates Increase, but Gaps Remain
December 2nd 2011
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer
2
Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights
3
GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival
4
FDA Approves Oral Nilotinib Tablets for Ph+ CML
5